Novo Nordisk shares rose sharply after the Danish pharmaceutical giant said an experimental weight-loss shot helped patients lose 22% of their body weight in a clinical trial.
Original Source Link
Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.